Colgate-Palmolive (NYSE:CL) Shares Bought by Alaska Permanent Fund Corp

Alaska Permanent Fund Corp lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 2.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,892 shares of the company’s stock after buying an additional 2,959 shares during the quarter. Alaska Permanent Fund Corp’s holdings in Colgate-Palmolive were worth $12,028,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. OFI Invest Asset Management acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $25,000. Avion Wealth raised its stake in Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new position in Colgate-Palmolive during the 4th quarter valued at $34,000. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after buying an additional 291 shares in the last quarter. Finally, West Branch Capital LLC raised its stake in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after buying an additional 132 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now owns 19,272 shares of the company’s stock, valued at $1,628,484. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the transaction, the insider now owns 57,948 shares in the company, valued at approximately $4,863,575.64. The disclosure for this sale can be found here. In the last three months, insiders sold 232,371 shares of company stock valued at $19,505,099. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $0.30 during trading hours on Thursday, hitting $89.17. 713,684 shares of the stock traded hands, compared to its average volume of 4,501,843. The stock has a market capitalization of $73.30 billion, a price-to-earnings ratio of 31.97, a P/E/G ratio of 3.33 and a beta of 0.42. The firm’s 50 day moving average price is $87.40 and its 200-day moving average price is $81.25. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $90.37.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. The company had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm’s revenue was up 6.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 earnings per share. As a group, equities analysts expect that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a dividend yield of 2.24%. Colgate-Palmolive’s payout ratio is currently 71.94%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of research analyst reports. StockNews.com lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Barclays lifted their price objective on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a research note on Friday, March 1st. They issued a “buy” rating and a $93.00 target price for the company. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research report on Thursday, January 18th. Finally, Wells Fargo & Company boosted their target price on Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $89.50.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.